Article

Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook

2023-06-01

Abstract excerpt

Triple negative breast cancer (TNBC) has a negative expression of estrogen receptors (ER), progesterone receptors (PR), or human epidermal growth factor receptors (HER2). The survival rate for TNBC is generally worse than other breast cancer subtypes. TNBC treatment has made significant advances, but certain limitations remain. Treatment for TNBC can be challenging since the disease has various subtypes. Individua...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c3427ca4-3c51-5359-ada9-7ddb620cbac1
DOI: 10.20944/preprints202306.0074.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Triple Negative Breast Cancer Treatment Options and Limitations: Future OutlookDOI 10.20944/preprints202306.0074.v1Read

Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC).Semantic proximity Read

Targeting Triple‐Negative Breast Cancer: Resistance Mechanisms and Therapeutic AdvancementsSemantic proximity Read

Treatment options for patients with triple-negative breast cancer.Semantic proximity Read

Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of researchSemantic proximity Read

Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast CancerSemantic proximity Read

New Biomarkers and Treatment Advances in Triple-Negative Breast CancerSemantic proximity Read

Triple-negative breast cancer: unique biology and its management.Semantic proximity Read

Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer.Semantic proximity Read

Triple-negative breast cancer and the need for new therapeutic targets.Semantic proximity Read

Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategiesSemantic proximity Read

Triple-Negative Breast Cancer: Molecular Particularities Still a ChallengeSemantic proximity Read

How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategiesSemantic proximity Read